Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out meperidine exposure. For follow-up testing of a presumptive result, Meperidine and Metabolite, Urine, Quantitative (3000248) is preferred.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens collected in tubes with additives or preservatives.

Remarks
Stability

Ambient: 1 week: Refrigerated: 1 month; Frozen: 1 month

Methodology

Qualitative Enzyme Immunoassay/Quantitative Gas Chromatography-Mass Spectrometry

Performed

Sun-Sat

Reported

1-6 days

Reference Interval

Interpretive Data

Methodology: Immunoassay

Positive Cutoff: 200 ng/mL

Compliance Category

FDA

Note

If the specimen screens positive, then Confirmation/Quantitation by GC-MS will be added to confirm result. See Meperidine and Metabolite Quantitative, Urine (3000248). Additional charges apply.

Hotline History

N/A

CPT Codes

80307; if reflexed, add 80362 (Reflexed Alt Code: G0480 )

Components

Component Test Code* Component Chart Name LOINC
2012212 Screen, Urine Interpretation 54247-2
2012289 Meperidine Screen, Urine 3746-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Dolantin
  • Pethanol
  • Centralgin
  • Lidol Mepergan
  • Normeperidine
  • Pethidine
  • Meperidine
  • Demerol
  • Dispadol
  • Dolosal
  • Dolsin
  • Isonipecaine
Meperidine, Urine Screen with Reflex to Quantitation